TB and HIV: A Double Burden in Public Health

The TB/HIV coinfection represents a major global public health challenge, with severe implications for morbidity and mortality. The complex interaction between these two conditions significa ntly increases the risk of rapid progression for both diseases. Recent studies highlight the need for early diagnosis using advanced methods, such as rapid molecular tests, and timely initiation of antiretroviral therapy to reduce incidence and mortality. Integrated strategies, including prevention and personalized treatment, are essential, especially in the context of drug-resistant forms. Despite progress, challenges related to stigma, limited access to treatment, and drug interactions require ongoing efforts to improve clinical outcomes.